Westway Health is a brand that specializes in health innovation and development, with a focus on finding solutions to address the growing threat of antibiotic resistance. As described by the World Health Organization, antibiotic resistance has become a major concern for public health, making it crucial to find alternative treatments for bacterial infections. Westway Health is at the forefront of developing non-antibiotic treatments that can effectively tackle these infections.

The brand's platform technologies have applications in various areas, including human health, animal health, and environmental projects. One of their standout products in development is PanaMast™ LC, which is the world's first zero withdrawal mastitis treatment. The goal of Westway Health is to bring innovative and safe solutions to the market, providing effective therapeutic care for infections without contributing to the problem of antibiotic resistance.

Through their active development programs, they aim to create solutions for a range of human and animal diseases. With their novel approach to anti-infective agents, Westway Health is leading the way in a post-antibiotic era to ensure the effective treatment of bacterial infections